mdt-20201002
0001613103Medtronic plcD02 XH02false00016131032020-10-022020-10-020001613103us-gaap:CommonStockMember2020-10-022020-10-020001613103mdt:SeniorNotes2019Due2021FloatingMember2020-10-022020-10-020001613103mdt:SeniorNotes2019Due2021Member2020-10-022020-10-020001613103mdt:SeniorNotes2019Due2022Member2020-10-022020-10-020001613103mdt:SeniorNotes2019Due20230.375PercentMember2020-10-022020-10-020001613103mdt:SeniorNotes2020Due2023Member2020-10-022020-10-020001613103mdt:SeniorNotes2019Due2025Member2020-10-022020-10-020001613103mdt:SeniorNotes2020Due2025Member2020-10-022020-10-020001613103mdt:SeniorNotes2019Due2027Member2020-10-022020-10-020001613103mdt:A2020SeniorNotesDue2028Member2020-10-022020-10-020001613103mdt:SeniorNotes2019Due20311.625PercentMember2020-10-022020-10-020001613103mdt:SeniorNotes2019Due20311.00PercentMember2020-10-022020-10-020001613103mdt:A2020SeniorNotesDue2032Member2020-10-022020-10-020001613103mdt:SeniorNotes2019Due20392.250PercentMember2020-10-022020-10-020001613103mdt:SeniorNotes2019Due20391.50PercentMember2020-10-022020-10-020001613103mdt:SeniorNotes2020Due2040Member2020-10-022020-10-020001613103mdt:SeniorNotes2019Due2049Member2020-10-022020-10-020001613103mdt:SeniorNotes2020Due2050Member2020-10-022020-10-02

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
_____________________________ 
FORM 8-K
 _____________________________ 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 2, 2020
 _____________________________ 
Medtronic Public Limited Company
(Exact Name of Registrant as Specified in its Charter)
  _____________________________ 
 
Ireland 1-36820 98-1183488
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)

20 On Hatch, Lower Hatch Street
Dublin 2, Ireland
(Address of principal executive offices)
+353 1 438-1700
(Registrant’s telephone number, including area code)
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))













Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Ordinary Shares, 00016131032020-10-022020-10-020001613103us-gaap:CommonStockMember2020-10-022020-10-020001613103mdt:SeniorNotes2019Due2021FloatingMember2020-10-022020-10-020001613103mdt:SeniorNotes2019Due2021Member2020-10-022020-10-020001613103mdt:SeniorNotes2019Due2022Member2020-10-022020-10-020001613103mdt:SeniorNotes2019Due20230.375PercentMember2020-10-022020-10-020001613103mdt:SeniorNotes2020Due2023Member2020-10-022020-10-020001613103mdt:SeniorNotes2019Due2025Member2020-10-022020-10-020001613103mdt:SeniorNotes2020Due2025Member2020-10-022020-10-020001613103mdt:SeniorNotes2019Due2027Member2020-10-022020-10-020001613103mdt:A2020SeniorNotesDue2028Member2020-10-022020-10-020001613103mdt:SeniorNotes2019Due20311.625PercentMember2020-10-022020-10-020001613103mdt:SeniorNotes2019Due20311.00PercentMember2020-10-022020-10-020001613103mdt:A2020SeniorNotesDue2032Member2020-10-022020-10-020001613103mdt:SeniorNotes2019Due20392.250PercentMember2020-10-022020-10-020001613103mdt:SeniorNotes2019Due20391.50PercentMember2020-10-022020-10-020001613103mdt:SeniorNotes2020Due2040Member2020-10-022020-10-020001613103mdt:SeniorNotes2019Due2049Member2020-10-022020-10-020001613103mdt:SeniorNotes2020Due2050Member2020-10-022020-10-02

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
_____________________________ 
FORM 8-K
 _____________________________ 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 2, 2020
 _____________________________ 
Medtronic Public Limited Company
(Exact Name of Registrant as Specified in its Charter)
  _____________________________ 
 
Ireland 1-36820 98-1183488
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)

20 On Hatch, Lower Hatch Street
Dublin 2, Ireland
(Address of principal executive offices)
+353 1 438-1700
(Registrant’s telephone number, including area code)
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))













Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Ordinary Shares, $0.0001 par value per shareMDTNew York Stock Exchange
Floating Rate Senior Notes due 2021MDT/21New York Stock Exchange
0.000% Senior Notes due 2021MDT/21ANew York Stock Exchange
0.00% Senior Notes due 2022MDT/22BNew York Stock Exchange
0.375% Senior Notes due 2023MDT/23BNew York Stock Exchange
0.000% Senior Notes due 2023
MDT/23CNew York Stock Exchange
0.25% Senior Notes due 2025MDT/25New York Stock Exchange
0.000% Senior Notes due 2025MDT/25ANew York Stock Exchange
1.125% Senior Notes due 2027MDT/27New York Stock Exchange
0.375% Senior Notes due 2028MDT/28New York Stock Exchange
1.625% Senior Notes due 2031MDT/31New York Stock Exchange
1.00% Senior Notes due 2031MDT/31ANew York Stock Exchange
0.750% Senior Notes due 2032MDT/32New York Stock Exchange
2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange
1.50% Senior Notes due 2039MDT/39BNew York Stock Exchange
1.375% Senior Notes due 2040MDT/40ANew York Stock Exchange
1.75% Senior Notes due 2049MDT/49New York Stock Exchange
1.625% Senior Notes due 2050MDT/50New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.






Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 2, 2020, Omar Ishrak, the former Chief Executive Officer of Medtronic plc (the “Company”) and currently the Company’s Executive Chairman and Chairman of the Board of Directors (the “Board”) of the Company, notified the Board of his voluntary decision to retire from the Company and not stand for reelection as a director at the Company’s 2020 Annual General Meeting of Shareholders, to be held on Friday, December 11, 2020 (the “2020 AGM”), and that in connection with his retirement he was tendering his resignation as Executive Chairman and Chairman of the Board of the Company, effective immediately prior to the start of the 2020 AGM. Mr. Ishrak’s decision to retire, not stand for reelection and resign as Executive Chairman and Chairman of the Board was not the result of any dispute or disagreement with the Company, the Company’s management or the Board on any matter relating to the operations, policies or practices of the Company.

On October 5, 2020, the Board (a) acknowledged Mr. Ishrak’s decision to retire and not stand for reelection to the Board at the 2020 AGM, (b) accepted Mr. Ishrak’s resignation as Executive Chairman and Chairman of the Board of the Company effective immediately prior to the start of the 2020 AGM, (c) appointed Geoffrey S. Martha, the Company’s Chief Executive Officer and a director, as the Chairman of the Board, effective immediately prior to the start of the 2020 AGM and (d) decreased the number of directors constituting the Board from thirteen (13) to twelve (12), effective immediately after the close of the 2020 AGM.







SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   MEDTRONIC PUBLIC LIMITED COMPANY
Date: October 6, 2020   By /s/ Bradley E. Lerman
   Bradley E. Lerman
   
Senior Vice President, General Counsel and Corporate Secretary




MDTNew York Stock Exchange
Floating Rate Senior Notes due 2021MDT/21New York Stock Exchange
0.000% Senior Notes due 2021MDT/21ANew York Stock Exchange
0.00% Senior Notes due 2022MDT/22BNew York Stock Exchange
0.375% Senior Notes due 2023MDT/23BNew York Stock Exchange
0.000% Senior Notes due 2023
MDT/23CNew York Stock Exchange
0.25% Senior Notes due 2025MDT/25New York Stock Exchange
0.000% Senior Notes due 2025MDT/25ANew York Stock Exchange
1.125% Senior Notes due 2027MDT/27New York Stock Exchange
0.375% Senior Notes due 2028MDT/28New York Stock Exchange
1.625% Senior Notes due 2031MDT/31New York Stock Exchange
1.00% Senior Notes due 2031MDT/31ANew York Stock Exchange
0.750% Senior Notes due 2032MDT/32New York Stock Exchange
2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange
1.50% Senior Notes due 2039MDT/39BNew York Stock Exchange
1.375% Senior Notes due 2040MDT/40ANew York Stock Exchange
1.75% Senior Notes due 2049MDT/49New York Stock Exchange
1.625% Senior Notes due 2050MDT/50New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.






Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 2, 2020, Omar Ishrak, the former Chief Executive Officer of Medtronic plc (the “Company”) and currently the Company’s Executive Chairman and Chairman of the Board of Directors (the “Board”) of the Company, notified the Board of his voluntary decision to retire from the Company and not stand for reelection as a director at the Company’s 2020 Annual General Meeting of Shareholders, to be held on Friday, December 11, 2020 (the “2020 AGM”), and that in connection with his retirement he was tendering his resignation as Executive Chairman and Chairman of the Board of the Company, effective immediately prior to the start of the 2020 AGM. Mr. Ishrak’s decision to retire, not stand for reelection and resign as Executive Chairman and Chairman of the Board was not the result of any dispute or disagreement with the Company, the Company’s management or the Board on any matter relating to the operations, policies or practices of the Company.

On October 5, 2020, the Board (a) acknowledged Mr. Ishrak’s decision to retire and not stand for reelection to the Board at the 2020 AGM, (b) accepted Mr. Ishrak’s resignation as Executive Chairman and Chairman of the Board of the Company effective immediately prior to the start of the 2020 AGM, (c) appointed Geoffrey S. Martha, the Company’s Chief Executive Officer and a director, as the Chairman of the Board, effective immediately prior to the start of the 2020 AGM and (d) decreased the number of directors constituting the Board from thirteen (13) to twelve (12), effective immediately after the close of the 2020 AGM.







SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   MEDTRONIC PUBLIC LIMITED COMPANY
Date: October 6, 2020   By /s/ Bradley E. Lerman
   Bradley E. Lerman
   
Senior Vice President, General Counsel and Corporate Secretary





v3.20.2
Document And Entity Information
Oct. 02, 2020
Entity Information [Line Items]  
Document Type 8-K
Document Period End Date Oct. 02, 2020
Entity Registrant Name Medtronic plc
Entity Incorporation, State or Country Code L2
Entity File Number 1-36820
Entity Tax Identification Number 98-1183488
Entity Address, Address Line One 20 On Hatch, Lower Hatch Street
Entity Address, City or Town Dublin 2
Entity Address, Country IE
Entity Address, Postal Zip Code D02 XH02
Country Region 353
City Area Code 1
Local Phone Number 438-1700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0001613103
Ordinary Shares, $0.0001 par value per share  
Entity Information [Line Items]  
Title of 12(b) Security Ordinary Shares, $0.0001 par value per share
Trading Symbol MDT
Security Exchange Name NYSE
Floating Rate Senior Notes due 2021  
Entity Information [Line Items]  
Title of 12(b) Security Floating Rate Senior Notes due 2021
Trading Symbol MDT/21
Security Exchange Name NYSE
0.000% Senior Notes due 2021  
Entity Information [Line Items]  
Title of 12(b) Security 0.000% Senior Notes due 2021
Trading Symbol MDT/21A
Security Exchange Name NYSE
0.00% Senior Notes due 2022  
Entity Information [Line Items]  
Title of 12(b) Security 0.00% Senior Notes due 2022
Trading Symbol MDT/22B
Security Exchange Name NYSE
0.375% Senior Notes due 2023  
Entity Information [Line Items]  
Title of 12(b) Security 0.375% Senior Notes due 2023
Trading Symbol MDT/23B
Security Exchange Name NYSE
0.000% Senior Notes due 2023  
Entity Information [Line Items]  
Title of 12(b) Security 0.000% Senior Notes due 2023
Trading Symbol MDT/23C
Security Exchange Name NYSE
0.25% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 0.25% Senior Notes due 2025
Trading Symbol MDT/25
Security Exchange Name NYSE
0.000% Senior Notes due 2025  
Entity Information [Line Items]  
Title of 12(b) Security 0.000% Senior Notes due 2025
Trading Symbol MDT/25A
Security Exchange Name NYSE
1.125% Senior Notes due 2027  
Entity Information [Line Items]  
Title of 12(b) Security 1.125% Senior Notes due 2027
Trading Symbol MDT/27
Security Exchange Name NYSE
0.375% Senior Notes due 2028  
Entity Information [Line Items]  
Title of 12(b) Security 0.375% Senior Notes due 2028
Trading Symbol MDT/28
Security Exchange Name NYSE
1.625% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 1.625% Senior Notes due 2031
Trading Symbol MDT/31
Security Exchange Name NYSE
1.00% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 1.00% Senior Notes due 2031
Trading Symbol MDT/31A
Security Exchange Name NYSE
0.750% Senior Notes due 2032  
Entity Information [Line Items]  
Title of 12(b) Security 0.750% Senior Notes due 2032
Trading Symbol MDT/32
Security Exchange Name NYSE
2.250% Senior Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 2.250% Senior Notes due 2039
Trading Symbol MDT/39A
Security Exchange Name NYSE
1.50% Senior Notes due 2039  
Entity Information [Line Items]  
Title of 12(b) Security 1.50% Senior Notes due 2039
Trading Symbol MDT/39B
Security Exchange Name NYSE
1.375% Senior Notes due 2040  
Entity Information [Line Items]  
Title of 12(b) Security 1.375% Senior Notes due 2040
Trading Symbol MDT/40A
Security Exchange Name NYSE
1.75% Senior Notes due 2049  
Entity Information [Line Items]  
Title of 12(b) Security 1.75% Senior Notes due 2049
Trading Symbol MDT/49
Security Exchange Name NYSE
1.625% Senior Notes due 2050  
Entity Information [Line Items]  
Title of 12(b) Security 1.625% Senior Notes due 2050
Trading Symbol MDT/50
Security Exchange Name NYSE